1. Home
  2. MYNZ vs SISI Comparison

MYNZ vs SISI Comparison

Compare MYNZ & SISI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYNZ
  • SISI
  • Stock Information
  • Founded
  • MYNZ 2021
  • SISI 1997
  • Country
  • MYNZ Germany
  • SISI China
  • Employees
  • MYNZ N/A
  • SISI N/A
  • Industry
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • SISI Medicinal Chemicals and Botanical Products
  • Sector
  • MYNZ Health Care
  • SISI Health Care
  • Exchange
  • MYNZ Nasdaq
  • SISI Nasdaq
  • Market Cap
  • MYNZ 6.1M
  • SISI 5.9M
  • IPO Year
  • MYNZ 2021
  • SISI 2016
  • Fundamental
  • Price
  • MYNZ $0.24
  • SISI $2.48
  • Analyst Decision
  • MYNZ Buy
  • SISI
  • Analyst Count
  • MYNZ 2
  • SISI 0
  • Target Price
  • MYNZ $3.00
  • SISI N/A
  • AVG Volume (30 Days)
  • MYNZ 5.2M
  • SISI 146.6K
  • Earning Date
  • MYNZ 11-26-2024
  • SISI 11-26-2024
  • Dividend Yield
  • MYNZ N/A
  • SISI N/A
  • EPS Growth
  • MYNZ N/A
  • SISI N/A
  • EPS
  • MYNZ N/A
  • SISI N/A
  • Revenue
  • MYNZ $917,203.00
  • SISI $10,330,284.00
  • Revenue This Year
  • MYNZ $36.69
  • SISI N/A
  • Revenue Next Year
  • MYNZ $91.67
  • SISI N/A
  • P/E Ratio
  • MYNZ N/A
  • SISI N/A
  • Revenue Growth
  • MYNZ 16.23
  • SISI 1680.61
  • 52 Week Low
  • MYNZ $0.19
  • SISI $2.33
  • 52 Week High
  • MYNZ $1.79
  • SISI $117.65
  • Technical
  • Relative Strength Index (RSI)
  • MYNZ 45.71
  • SISI 32.25
  • Support Level
  • MYNZ $0.22
  • SISI $2.33
  • Resistance Level
  • MYNZ $0.36
  • SISI $3.10
  • Average True Range (ATR)
  • MYNZ 0.04
  • SISI 0.52
  • MACD
  • MYNZ 0.00
  • SISI 0.11
  • Stochastic Oscillator
  • MYNZ 18.59
  • SISI 8.02

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.

About SISI Shineco Inc.

Shineco Inc aims to care for a healthy life and improve the quality of life by providing safe, efficient, and high-quality health products and services to society. The company has researched and developed various vitro diagnostic reagents and related medical devices to date, and it also produces and sells healthy and nutritious food.

Share on Social Networks: